The Liggins Institute, and National Research Centre for Growth and Development, University of Auckland, 2-6 Park Avenue, Private Bag 92019, Auckland, New Zealand.
Nutr Metab (Lond). 2010 May 20;7:44. doi: 10.1186/1743-7075-7-44.
The detrimental effects of maternal under-nutrition during gestation on fetal development are well known with an increased propensity of metabolic disorders identified in the adult offspring. Understanding exactly how and by which molecular pathways inadequate nutrition can impact upon offspring phenotype is critical and necessary for the development of treatment methods and ultimately prevention of any negative health effects. Myostatin, a negative regulator of muscle development, has recently been shown to effect glucose homeostasis and fat deposition. The involvement of myostatin in glucose metabolism and adipogenesis thus supports its ability to act in the continued alterations to the postnatal phenotype of the offspring. This hypothesis was examined in the current study using a trans-generational gestationally under-nourished rat model exposed to a high-fat (HF) diet post-weaning. The body weight, body fat, plasma glucose and insulin concentrations of the offspring, both male and female, were investigated in relation to the protein expression of myostatin and its main inhibitor; follistatin like-3 (FSTL-3), in skeletal muscle of mature offspring. Sexual dimorphism was clearly evident in the majority of these measures, including myostatin and FSTL-3 expression. Generally males displayed higher (P < 0.05) myostatin precursor and dimer expression than females, which was especially apparent (P < 0.01) in both chow and HF trans-generationally undernourished (UNAD) groups. In females only, myostatin precursor and dimer expression was altered by both trans-generational under-nutrition and postnatal diet. Overall FSTL-3 expression did not differ between sexes, although difference between sexes within certain treatments and diets were evident. Most notably, HF fed UNAD females had higher (P < 0.05) FSTL-3 expression than HF fed UNAD males. The former group also displayed higher (P < 0.01) FSTL-3 expression compared to all other female groups. In summary, myostatin may prove to be a key mediator of the effects of inadequate prenatal nutrition, independently or in combination with a high-fat postnatal diet on offspring phenotype. Consequently, further study of myostatin may provide a novel therapeutic pathway for the treatment of metabolic disorders; however, it is vital that the influence of nutrition and gender should be taken into consideration.
众所周知,母亲在妊娠期间营养不足会对胎儿发育产生有害影响,并且成年后代更容易出现代谢紊乱。确切了解营养不足如何以及通过哪些分子途径影响后代的表型是至关重要的,这是开发治疗方法并最终预防任何健康负面影响的必要条件。肌肉生长抑制素(Myostatin)是肌肉发育的负调节剂,最近已被证明可影响葡萄糖稳态和脂肪沉积。肌肉生长抑制素在葡萄糖代谢和脂肪生成中的作用支持了其在后代出生后表型的持续改变中发挥作用的能力。本研究采用经代际妊娠期营养不良的大鼠模型,在断奶后给予高脂肪(HF)饮食,检验了这一假说。研究调查了雄性和雌性后代的体重、体脂肪、血浆葡萄糖和胰岛素浓度与成熟后代骨骼肌中肌肉生长抑制素及其主要抑制剂——卵泡抑素样 3(Follistatin-like 3,FSTL-3)的蛋白表达之间的关系。这些指标中的大多数都表现出明显的性别二态性,包括肌肉生长抑制素和 FSTL-3 的表达。通常,雄性的肌肉生长抑制素前体和二聚体表达高于雌性(P<0.05),在正常饮食和高脂肪经代际营养不良(UNAD)组中尤其明显(P<0.01)。只有雌性的肌肉生长抑制素前体和二聚体表达受到经代际营养不良和产后饮食的改变。总体而言,FSTL-3 的表达在性别之间没有差异,但在某些处理和饮食中存在性别差异。最值得注意的是,高脂肪喂养的经代际营养不良雌性的 FSTL-3 表达高于高脂肪喂养的经代际营养不良雄性(P<0.05)。前者的 FSTL-3 表达也高于所有其他雌性组(P<0.01)。总之,肌肉生长抑制素可能是胎儿期营养不足对后代表型的影响的关键调节因子,无论是独立作用还是与高脂肪产后饮食联合作用。因此,进一步研究肌肉生长抑制素可能为代谢紊乱的治疗提供一种新的治疗途径;然而,必须考虑营养和性别对其的影响。